Amphastar Pharmaceuticals Inc (AMPH)
40.03
+1.40
(+3.62%)
USD |
NASDAQ |
Apr 19, 16:00
40.03
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Market Cap: 1.925B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 1.858B |
| April 17, 2024 | 1.926B |
| April 16, 2024 | 1.967B |
| April 15, 2024 | 1.961B |
| April 12, 2024 | 1.906B |
| April 11, 2024 | 1.931B |
| April 10, 2024 | 1.926B |
| April 09, 2024 | 1.967B |
| April 08, 2024 | 1.974B |
| April 05, 2024 | 2.010B |
| April 04, 2024 | 1.997B |
| April 03, 2024 | 2.017B |
| April 02, 2024 | 2.035B |
| April 01, 2024 | 2.089B |
| March 28, 2024 | 2.112B |
| March 27, 2024 | 2.093B |
| March 26, 2024 | 2.078B |
| March 25, 2024 | 2.098B |
| March 22, 2024 | 2.102B |
| March 21, 2024 | 2.142B |
| March 20, 2024 | 2.118B |
| March 19, 2024 | 2.144B |
| March 18, 2024 | 2.061B |
| March 15, 2024 | 2.071B |
| March 14, 2024 | 2.077B |
| Date | Value |
|---|---|
| March 13, 2024 | 2.095B |
| March 12, 2024 | 2.123B |
| March 11, 2024 | 2.107B |
| March 08, 2024 | 2.197B |
| March 07, 2024 | 2.249B |
| March 06, 2024 | 2.227B |
| March 05, 2024 | 2.276B |
| March 04, 2024 | 2.245B |
| March 01, 2024 | 2.223B |
| February 29, 2024 | 2.240B |
| February 28, 2024 | 2.633B |
| February 27, 2024 | 2.666B |
| February 26, 2024 | 2.650B |
| February 23, 2024 | 2.569B |
| February 22, 2024 | 2.497B |
| February 21, 2024 | 2.464B |
| February 20, 2024 | 2.521B |
| February 16, 2024 | 2.599B |
| February 15, 2024 | 2.668B |
| February 14, 2024 | 2.640B |
| February 13, 2024 | 2.632B |
| February 12, 2024 | 2.693B |
| February 09, 2024 | 2.673B |
| February 08, 2024 | 2.625B |
| February 07, 2024 | 2.546B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
585.38M
Minimum
Mar 20 2020
3.176B
Maximum
Aug 08 2023
1.387B
Average
1.020B
Median
Aug 02 2021
Market Cap Benchmarks
| Eli Lilly and Co | 690.59B |
| Dentsply Sirona Inc | 6.324B |
| Pacira BioSciences Inc | 1.220B |
| Organon & Co | 4.554B |
| NovaBay Pharmaceuticals Inc | 2.441M |
Market Cap Related Metrics
| PE Ratio | 15.52 |
| PS Ratio | 3.292 |
| PEG Ratio | 0.3330 |
| Price to Book Value | 3.011 |
| Price to Free Cash Flow | 14.60 |
| Price | 40.03 |
| Earnings Yield | 6.45% |
| PEGY Ratio | 0.3330 |
| Operating PE Ratio | 10.77 |
| Normalized PE Ratio | 15.52 |